Glansbeek HL - Search Results

1

Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.

Schutte K, Szczepanska A, Halder M, Cussler K, Sauer UG, Stirling C, Uhlrich S, Wilk-Zasadna I, John D, Bopst M, Garbe J, Glansbeek HL, Levis R, Serreyn PJ, Smith D, Stickings P. Schutte K, et al. Among authors: glansbeek hl. Biologicals. 2017 Jul;48:55-65. doi: 10.1016/j.biologicals.2017.05.006. Epub 2017 Jun 7. Biologicals. 2017. PMID: 28596049 Free article.

2

Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.

van Kessel G, Geels MJ, de Weerd S, Buijs LJ, de Bruijni MA, Glansbeek HL, van den Bosch JF, Heldens JG, van den Heuvel ER. van Kessel G, et al. Among authors: glansbeek hl. Vaccine. 2012 Jan 5;30(2):201-9. doi: 10.1016/j.vaccine.2011.11.023. Epub 2011 Nov 19. Vaccine. 2012. PMID: 22107849 Free article.

3

Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits.

Heldens JG, Glansbeek HL, Hilgers LA, Haenen B, Stittelaar KJ, Osterhaus AD, van den Bosch JF. Heldens JG, et al. Among authors: glansbeek hl. Vaccine. 2010 Nov 29;28(51):8125-31. doi: 10.1016/j.vaccine.2010.09.097. Epub 2010 Oct 13. Vaccine. 2010. PMID: 20950729

4

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.

Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, Betbeder D, Vromans H, Jiskoot W. Hagenaars N, et al. Vaccine. 2008 Dec 2;26(51):6555-63. doi: 10.1016/j.vaccine.2008.09.057. Vaccine. 2008. PMID: 18848856

5

Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration.

Hagenaars N, Mastrobattista E, Verheul RJ, Mooren I, Glansbeek HL, Heldens JG, van den Bosch H, Jiskoot W. Hagenaars N, et al. Among authors: glansbeek hl. Pharm Res. 2009 Jun;26(6):1353-64. doi: 10.1007/s11095-009-9845-y. Epub 2009 Feb 18. Pharm Res. 2009. PMID: 19224344

6

Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.

Voeten JT, Kiseleva IV, Glansbeek HL, Basten SM, Drieszen-van der Cruijsen SK, Rudenko LG, van den Bosch H, Heldens JG. Voeten JT, et al. Among authors: glansbeek hl. Arch Virol. 2010 Sep;155(9):1391-9. doi: 10.1007/s00705-010-0719-8. Epub 2010 Jun 10. Arch Virol. 2010. PMID: 20532926 Free article.

7

Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.

Hagenaars N, Verheul RJ, Mooren I, de Jong PH, Mastrobattista E, Glansbeek HL, Heldens JG, van den Bosch H, Hennink WE, Jiskoot W. Hagenaars N, et al. Among authors: glansbeek hl. J Control Release. 2009 Dec 3;140(2):126-33. doi: 10.1016/j.jconrel.2009.08.018. Epub 2009 Aug 25. J Control Release. 2009. PMID: 19712713

8

Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.

Hagenaars N, Mania M, de Jong P, Que I, Nieuwland R, Slütter B, Glansbeek H, Heldens J, van den Bosch H, Löwik C, Kaijzel E, Mastrobattista E, Jiskoot W. Hagenaars N, et al. J Control Release. 2010 May 21;144(1):17-24. doi: 10.1016/j.jconrel.2010.01.027. Epub 2010 Jan 25. J Control Release. 2010. PMID: 20100528

9

A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine.

Verheul RJ, Hagenaars N, van Es T, van Gaal EV, de Jong PH, Bruijns S, Mastrobattista E, Slütter B, Que I, Heldens JG, van den Bosch H, Glansbeek HL, Hennink WE, Jiskoot W. Verheul RJ, et al. Among authors: glansbeek hl. Eur J Pharm Sci. 2012 Mar 12;45(4):467-74. doi: 10.1016/j.ejps.2011.10.001. Epub 2011 Oct 8. Eur J Pharm Sci. 2012. PMID: 22009112

10

Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.

van Rooij EM, Glansbeek HL, Hilgers LA, te Lintelo EG, de Visser YE, Boersma WJ, Haagmans BL, Bianchi AT. van Rooij EM, et al. Among authors: glansbeek hl. J Virol. 2002 Oct;76(20):10540-5. doi: 10.1128/jvi.76.20.10540-10545.2002. J Virol. 2002. PMID: 12239334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page